Strong Medicine: Using Investment Treaties to Mitigate Foreign Regulatory Risk in the Life Sciences | White & Case LLP
The COVID-19 pandemic has accelerated the globalization of the life sciences industry, driving cross-border collaborations to develop urgently needed treatments, scale up manufacturing...